D-0005-2021 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

FDA drug recall D-0005-2021 was initiated by PD-Rx Pharmaceuticals, Inc. on Sep 17, 2020 and is designated Class II. Reason for recall: CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent. The recall status is terminated (terminated Nov 5, 2021). Affected quantity: 20 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 14, 2020
Initiation Date
Sep 17, 2020
Termination Date
Nov 5, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 bottles

Product description

Nature-Throid 1 GR (65 mg), Each Tablet Contains: Thyroid USP 1 GR (65 mg), Liothyronine (T3) 9 mcg, Levothyroxine (T4) 38 mcg, 100 Tablets per bottle, Rx Only, Pkg By PD-Rx Pharmaceuticals Incorporated, Oklahoma City, OK 73127, NDC 43063-819-01.

Reason for recall

CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.

Distribution pattern

AZ, OK

Code information

Lot #: J18C68 Exp. 10/31/20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0005-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0005-2021. Report a data issue: hello@regdatalab.com.